Home
ENLV
ENLV News

Latest Enlivex Therapeutics Ltd. (ENLV) News on July 5, 2025

ACCESS Newswire

22 days ago

Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology

GlobeNewswire

25 days ago

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology

Enlivex Selected to Present at Israeli BioMed 2025 Conference

GlobeNewswire

2 months ago

Enlivex Selected to Present at Israeli BioMed 2025 Conference

Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress

GlobeNewswire

2 months ago

Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress

Enlivex enrols all patients in Phase II stage of knee osteoarthritis trial

Clinical Trials Arena

2 months ago

Enlivex enrols all patients in Phase II stage of knee osteoarthritis trial

Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis

GlobeNewswire

2 months ago

Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis

Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Invest In Growth?

Simply Wall St.

3 months ago

Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Invest In Growth?

Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

GlobeNewswire

3 months ago

Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

GlobeNewswire

4 months ago

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis

GlobeNewswire

4 months ago

Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis

Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis

GlobeNewswire

4 months ago

Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis

Enlivex Issues Urgent Statement on Fraudulent News Dissemination

GlobeNewswire

5 months ago

Enlivex Issues Urgent Statement on Fraudulent News Dissemination

RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis

ACCESS Newswire

5 months ago

RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

6 months ago

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Enlivex gains Israeli regulatory approval to commence TMJ osteoarthritis trial

Clinical Trials Arena

7 months ago

Enlivex gains Israeli regulatory approval to commence TMJ osteoarthritis trial

MT Newswires

7 months ago

Enlivex Therapeutics Gets Approval for Phase 1 Trial of Allocetra to Treat Osteoarthritis

Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

GlobeNewswire

7 months ago

Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

GlobeNewswire

7 months ago

Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3

ACCESSWIRE

7 months ago

Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3

MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Barrons.com

7 months ago

MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis

GlobeNewswire

8 months ago

Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis

Enlivex Announces the Enrollment and Dosing of the First 10 Patient in the Randomized Phase II Stage of its Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

GlobeNewswire

8 months ago

Enlivex Announces the Enrollment and Dosing of the First 10 Patient in the Randomized Phase II Stage of its Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

Enlivex Therapeutics (ENLV) Upgraded to Strong Buy: Here's What You Should Know

Zacks

8 months ago

Enlivex Therapeutics (ENLV) Upgraded to Strong Buy: Here's What You Should Know

MT Newswires

8 months ago

Enlivex Therapeutics Gets Japan Patent Notice for Allocetra in Osteoarthritis Treatment

Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis

GlobeNewswire

8 months ago

Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis

Enlivex Receives Authorization from the Danish Medicines Agency to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

GlobeNewswire

9 months ago

Enlivex Receives Authorization from the Danish Medicines Agency to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

GlobeNewswire

9 months ago

Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

All You Need to Know About Enlivex Therapeutics (ENLV) Rating Upgrade to Buy

Zacks

10 months ago

All You Need to Know About Enlivex Therapeutics (ENLV) Rating Upgrade to Buy

GreenPower and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

10 months ago

GreenPower and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

MT Newswires

a year ago

Enlivex Therapeutics Gets Regulatory Nod in Israel to Begin Phase I Trial for Potential Psoriatic Arthritis Treatment

Enlivex Receives Regulatory Authorization For The Initiation Of A Phase I Clinical Trial To Evaluate Allocetra In Patients With Psoriatic Arthritis

GlobeNewswire

a year ago

Enlivex Receives Regulatory Authorization For The Initiation Of A Phase I Clinical Trial To Evaluate Allocetra In Patients With Psoriatic Arthritis

Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

a year ago

Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

MT Newswires

a year ago

Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial

Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis

GlobeNewswire

a year ago

Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis

Join Enlivex Therapeutics’ Chief Executive Officer for a Live Investor Webinar and Q&A Session on June 25

GlobeNewswire

a year ago

Join Enlivex Therapeutics’ Chief Executive Officer for a Live Investor Webinar and Q&A Session on June 25

Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis

GlobeNewswire

a year ago

Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis

Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis

GlobeNewswire

a year ago

Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis

Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering

GlobeNewswire

a year ago

Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering

MT Newswires

a year ago

Enlivex Therapeutics to Launch Registered Direct Offering; Shares Fall

Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering

GlobeNewswire

a year ago

Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering

We're Keeping An Eye On Enlivex Therapeutics' (NASDAQ:ENLV) Cash Burn Rate

Simply Wall St.

a year ago

We're Keeping An Eye On Enlivex Therapeutics' (NASDAQ:ENLV) Cash Burn Rate

Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events

GlobeNewswire

a year ago

Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events

Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis

GlobeNewswire

a year ago

Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis

Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis

GlobeNewswire

a year ago

Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis

Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why

Zacks

a year ago

Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why

Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis

GlobeNewswire

a year ago

Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis

Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis

GlobeNewswire

a year ago

Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis

Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

a year ago

Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis

ACCESSWIRE

a year ago

Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis

Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals

ACCESSWIRE

a year ago

Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals

Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method

GlobeNewswire

a year ago

Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method

Business Wire

a year ago

MFS Announces Closed-End Fund Distributions

Natural Gas Services Group, Inc. Announces Justin Jacobs as Chief Executive Officer

GlobeNewswire

a year ago

Natural Gas Services Group, Inc. Announces Justin Jacobs as Chief Executive Officer

Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors

PR Newswire

a year ago

Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits

NewMediaWire

a year ago

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

GlobeNewswire

a year ago

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

Evolution Petroleum (EPM) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

a year ago

Evolution Petroleum (EPM) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Syntec Optics (Nasdaq: OPTX) to Display Innovations at Photonics West 2024

GlobeNewswire

a year ago

Syntec Optics (Nasdaq: OPTX) to Display Innovations at Photonics West 2024

Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis

GlobeNewswire

a year ago

Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

InvestorPlace

a year ago

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

Richardson Electronics (NASDAQ:RELL) Is Paying Out A Dividend Of $0.06

Simply Wall St.

a year ago

Richardson Electronics (NASDAQ:RELL) Is Paying Out A Dividend Of $0.06

Is It Time To Consider Buying Richardson Electronics, Ltd. (NASDAQ:RELL)?

Simply Wall St.

a year ago

Is It Time To Consider Buying Richardson Electronics, Ltd. (NASDAQ:RELL)?

ACCESSWIRE

2 years ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Pixelworks X7 Gen 2 Visual Processor Makes Debut in OnePlus Ace 3 Smartphone

PR Newswire

2 years ago

Pixelworks X7 Gen 2 Visual Processor Makes Debut in OnePlus Ace 3 Smartphone

Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director

GlobeNewswire

2 years ago

Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director

Business Wire

2 years ago

Rocky Brands, Inc. to Present at the 2024 ICR Conference

Modiv Industrial Declares Distribution of GIPR Common Shares

Business Wire

2 years ago

Modiv Industrial Declares Distribution of GIPR Common Shares

4 Solid Stocks to Buy on Rise in Personal Income, Spending

Zacks

2 years ago

4 Solid Stocks to Buy on Rise in Personal Income, Spending

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

GlobeNewswire

2 years ago

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Income Investors Should Know That Townsquare Media, Inc. (NYSE:TSQ) Goes Ex-Dividend Soon

Simply Wall St.

2 years ago

Income Investors Should Know That Townsquare Media, Inc. (NYSE:TSQ) Goes Ex-Dividend Soon

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION

CNW Group

2 years ago

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION

Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis

GlobeNewswire

2 years ago

Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis

Westport Awarded Development Contract with a Global Heavy Truck Manufacturer to Adapt and Commercialize Next Gen LNG HPDI™ Fuel System for the Euro 7 Vehicle Platform

PR Newswire

2 years ago

Westport Awarded Development Contract with a Global Heavy Truck Manufacturer to Adapt and Commercialize Next Gen LNG HPDI™ Fuel System for the Euro 7 Vehicle Platform

Peoples Bancorp Announces Authorization of Stock Repurchase Plan

ACCESSWIRE

2 years ago

Peoples Bancorp Announces Authorization of Stock Repurchase Plan

CVG Announces Election of William C. Johnson to Board of Directors

GlobeNewswire

2 years ago

CVG Announces Election of William C. Johnson to Board of Directors

Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

2 years ago

Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Deliver On Growth Plans?

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing

GlobeNewswire

2 years ago

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing

CPI Card Group Announces Share Purchase Agreement with Majority Shareholder Parallel49 Equity ULC

Business Wire

2 years ago

CPI Card Group Announces Share Purchase Agreement with Majority Shareholder Parallel49 Equity ULC

IX Acquisition Corp. Announces Increase in Contribution Amount in Connection with its Proposed Extension

GlobeNewswire

2 years ago

IX Acquisition Corp. Announces Increase in Contribution Amount in Connection with its Proposed Extension

Fenbo Holdings Limited Announces Closing of Its Initial Public Offering

GlobeNewswire

2 years ago

Fenbo Holdings Limited Announces Closing of Its Initial Public Offering

ACRES Commercial (ACR) Expands Share Buyback Program by $10M

Zacks

2 years ago

ACRES Commercial (ACR) Expands Share Buyback Program by $10M

System1 to Participate in The Benchmark Company’s Discovery One-on-One Investor Conference

Business Wire

2 years ago

System1 to Participate in The Benchmark Company’s Discovery One-on-One Investor Conference

There's A Lot To Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming US$0.19 Dividend

Simply Wall St.

2 years ago

There's A Lot To Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming US$0.19 Dividend

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer

GlobeNewswire

2 years ago

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

Business Wire

2 years ago

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

PR Newswire

2 years ago

Prenetics Announces Third Quarter 2023 Financial Results

13 Cheap Monthly Dividend Stocks to Buy

Insider Monkey

2 years ago

13 Cheap Monthly Dividend Stocks to Buy

Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

Business Wire

2 years ago

Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

Business Wire

2 years ago

MFS High Yield Municipal Trust Announces Final Results of Tender Offer

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

Simply Wall St.

2 years ago

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Simply Wall St.

2 years ago

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Provident Financial Holdings (NASDAQ:PROV) Could Be A Buy For Its Upcoming Dividend

Simply Wall St.

2 years ago

Provident Financial Holdings (NASDAQ:PROV) Could Be A Buy For Its Upcoming Dividend

Tortoise Announces Distribution Amounts for its Closed-End Funds

ACCESSWIRE

2 years ago

Tortoise Announces Distribution Amounts for its Closed-End Funds

Vox Announces Q3 2023 Financial Results and Declares Quarterly Dividend

ACCESSWIRE

2 years ago

Vox Announces Q3 2023 Financial Results and Declares Quarterly Dividend

Business Wire

2 years ago

MFS High Yield Municipal Trust Announces Preliminary Results of Tender Offer

Atomera Incorporated (NASDAQ:ATOM) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Atomera Incorporated (NASDAQ:ATOM) Q3 2023 Earnings Call Transcript

Prenetics Global Limited Announces Reverse Stock Split

GlobeNewswire

2 years ago

Prenetics Global Limited Announces Reverse Stock Split

Share on Social Networks: